MKI67 and central nervous system cancer: In comparison with control brain tissues and grade I and II gliomas, Ki-67 LI was significantly increased in grade III gliomas (P < 0.05 ∼ 0.001) and was the highest in glioblastoma (P < 0.001; Supplementary Figure S2A and S2B).